BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 161669)

  • 1. The interaction between heparin and plasmin on amidolysis.
    Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
    Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmin potency estimates: influence of the substrate used in assay.
    Philo RD; Gaffney PJ
    Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of fibrinolysis in amniotic fluid.
    Walker JE; Campbell DM; Ogston D
    Thromb Haemost; 1980 Aug; 44(1):32-4. PubMed ID: 6968460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM; Dosne AM; Kher A; Samama M
    Thromb Haemost; 1989 Nov; 62(3):923-6. PubMed ID: 2556812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-oleoyl heparin inhibits the amidolytic activity of plasmin and urokinase.
    Legras S; Diczhazi C; Moczar M
    Int J Biol Macromol; 1992 Apr; 14(2):97-9. PubMed ID: 1387549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
    Pućkowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.